Impact of Laser-modified Abutment Topography on Peri-implant Mucosal Integration
NCT ID: NCT03982615
Last Updated: 2021-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2019-05-08
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each subject will receive two implants. Following placement of the two 4.2mm diameter implants, one implant will receive (by randomization) a laser-etched abutment ('Laser-Lok'). The other implant will receive a standard, non-etched healing abutment. Subjects will be sequentially subdivided into four groups (n=5) and scheduled for a biopsy of the peri-implant tissues of both implants at either 8 weeks, 4 weeks, 2 weeks or 1 week after implant surgery. These biopsies, about the size of a grain of rice, will be analyzed using immunohistochemical and RNASeq techniques to identify molecular changes in response to laser etching.
At approximately 8 weeks after implant surgery, subjects will have abutments removed from both implants and digital impressions taken for final crown fabrication. At approximately 11-12 weeks after implant surgery, final crowns will be placed. Subjects return to clinic at approximately 1 year post surgery for a final study visit to assess the peri-implant mucosa surrounding both implants as measured by bleeding upon probing, probing depth and peri-apical radiography.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments to Promote Tissue Healing
NCT01822223
Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans
NCT01954485
Comparing Pro-Inflammatory Cytokines and Bone Metabolism Mediators Around Laser-Lok and Machined Transmucosal Abutments
NCT03572244
Therapeutic Peri-implant Maintenance with Laser Therapy
NCT04251793
A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants
NCT01899131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Osseointegration is defined as the fusion of a dental implant and abutment with the surrounding jaw bone and is a critical step during implant therapy. During this process, the titanium and bone need to become one solid structure (without any intervening inflammatory mucosal tissue in between) for optimum strength and viability.
It is hypothesized that use of an abutment whose surface has been etched with a laser ("laser-etched") will enhance the attachment of the abutment to the surrounding bone and mucosal tissue and optimize healing.
The goal of this research is to compare, by split mouth design, the healing process of peri-implant mucosal tissue adjacent to a standard healing abutment (not laser-etched) versus mucosal tissue healing adjacent to a laser-etched abutment .
Each subject will receive two implants. One implant will receive (by randomization) a standard titanium healing abutment that is not laser-etched. The other implant will receive a laser-etched ("Laser-Lok") abutment. Subjects will be sequentially subdivided into 4 groups (n=5) and scheduled for a biopsy of peri-implant tissue at both implant sites at either 8 weeks, 4 weeks, 2 weeks or 1 week after implant surgery. The biopsies, about the size of a grain of rice, will be analyzed using histological and molecular techniques to identify cellular changes in response to laser-etching.
Approximately 8 weeks after implant placement, subject will have abutments removed and digital impressions taken for final crown fabrication. At approximately 11-12 weeks post implant placement, final crowns will be placed. Subjects return to clinic at approximately 1 year post surgery for a final study visit to assess the peri-implant mucosa around both implants as measured by bleeding upon probing, probing depth and peri-apical radiography.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Each subject will receive two dental implants. One implant will receive (by randomization) a laser-etched ("Laser-Lok") abutment. The other implant will receive a standard healing abutment (not laser-etched).
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laser-Lok abutment
Laser-etched abutment
Laser-Lok abutment
Each subject will receive two dental implants. One implant will receive (by randomization) a laser-etched ("Laser-Lok") abutment.
Standard Healing abutment
Standard abutment which is not laser-etched
Standard healing abutment
Each subject will receive two dental implants. One implant will receive (by randomization) receive a standard healing abutment (not laser-etched).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser-Lok abutment
Each subject will receive two dental implants. One implant will receive (by randomization) a laser-etched ("Laser-Lok") abutment.
Standard healing abutment
Each subject will receive two dental implants. One implant will receive (by randomization) receive a standard healing abutment (not laser-etched).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have 2 edentulous sites requiring single tooth implants for restoration in two separate quadrants
* Implant sites must be restorable with 4.2mm diameter implants
* Have natural teeth adjacent (at least unilaterally) to proposed implant sites
* Able to pay for implant crowns at UIC College of Dentistry postgraduate fees to complete treatment
Exclusion Criteria
* Unable to demonstrate adequate home oral hygiene
* smoker within the past 6 months
* ASA Class 3+, immune-compromised
* Pregnant or planning to become pregnant within 6 months
* Severe bruxism
* History of bisphosphonate use
* Bone grafting required for implant placement
* Missing tooth is too small to be restored using a 4.2mm implant
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioHorizons, Inc.
INDUSTRY
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyndon F Cooper
Associate Dean of Research, Chair-Department of Oral Biology, College of Dentistry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndon F Cooper, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago College of Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois at Chicago, College of Dentistry, Clinical Research Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Leong A, De Kok I, Mendonca D, Cooper LF. Molecular Assessment of Human Peri-implant Mucosal Healing at Laser-Modified and Machined Titanium Abutments. Int J Oral Maxillofac Implants. 2018 Jul/Aug;33(4):895-904. doi: 10.11607/jomi.6367.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-1358
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.